CoxaPro > Clinical Library > Tervetuloa Clinical Libraryyn > Efficacy of fondaparinux for thromboprophylaxis in high-risk patients undergoing hip fracture surgery
ABSTRACT| VOLUME 19, ISSUE 2, P259, FEBRUARY 01, 2004

Efficacy of fondaparinux for thromboprophylaxis in high-risk patients undergoing hip fracture surgery

Clifford W. Colwell Jr, MD M.R. Lassen B.I. Eriksson
Hip
Extended prophylaxis with fondaparinux may be even more beneficial for high-risk patients undergoing hip fracture surgery. We evaluated the efficacy of fondaparinux for thromboprophylaxis in predefined high-risk patients (female gender, age over 75 years, and impaired renal function) in the PENTHIFRA-PLUS trial.

Link to article